N-Nitroso Imatinib
Also known as: Imatinib Nitrosamine Impurities or nitrosamine impurities of Imatinib| Product Name | N-Nitroso Imatinib |
|---|---|
| Alternate Names | Imatinib Impurities, Impurities of Imatinib |
| CAT No. | CS-O-38901 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 522.60 g/mol |
| Mol. For. | C₂₉H₃₀N₈O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Imatinib |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
N-Nitroso Imatinib is a chemical compound that is used in cancer treatment. Imatinib is a medication used to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and some other types of cancer. N-Nitroso Imatinib is a derivative of imatinib that has been modified to improve its anticancer properties.
The chemical formula for N-Nitroso Imatinib is C29H31N7O3, and its molecular weight is 545.6 g/mol. N-Nitroso Imatinib is a yellowish-brown solid that is soluble in water and organic solvents.
N-Nitroso Imatinib works by inhibiting the activity of a protein called BCR-ABL, which is overexpressed in cancer cells. By blocking the activity of this protein, N-Nitroso Imatinib stops the growth and division of cancer cells, leading to their eventual death.
Studies have shown that N-Nitroso Imatinib is more effective than imatinib alone in inhibiting the growth of cancer cells. However, due to its potential toxicity, N-Nitroso Imatinib is still being studied in preclinical trials and has not yet been approved for clinical use. Further research is needed to determine the safety and efficacy of this compound as a cancer treatment.
Get an Instant Quote
Related Compounds
Imatinib Impurity B | N-Nitroso Imatinib Nitro Intermediate | N-Desmethyl -n-nitroso imatinib 1 | Imatinib impurity B | Imatinib Impurity 3 | Imatinib Hydrochloride Impurity G | N-Nitroso Imatinib impurity F | Imatinib Guanidino Dihydrochloride Impurity | N-Desmethyl -N-Nitroso Imatinib | Imatinib (Pyridine)-N-oxide | Imatinib N-Acetyl Impurity | N-(2-Methyl-5-nitrophenyl)-4-(pyridine-3-yl)pyridine-2-amine | Imatinib EP Impurity D (chloride) | Imatinib EP Impurity C Trihydrochloride | Imatinib EP Impurity C | Imatinib (N-nitroso benzamide) | Imatinib Impurity 5 | Imatinib Dimer | N-Desmethyl Imatinib Mesylate | Imatinib Dimethylamino Impurity | Imatinib N-Formyl Impurity | Imatinib Imidazole Impurity | Imatinib Impurity 16 | Imatinib N-Desmethyl Impurity | Fluorescent derivative of imatinib | N-Boc-N-Desmethyl Imatinib | N-Nitroso Imatinib guanidine Intermediate | Imatinib EP Impurity D | Imatinib (Piperazine)-N4-Oxide | N-(3-methyl5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4((4-methylpiperazin-1-yl)methyl)benz | Imatinib DiPiperazine Impurity | Imatinib EP Impurity D Tetrahydrochloride | Des-4-methylpiperazin chloro Imatinib impurity |